Rod cells manage low-light vision, cone cells handle daylight and colour, and ‘rod-cone dystrophy’ is simply a label for which group gives way first. In this pattern it is the rods, with cone involvement following at a later stage — and that particular sequence is what places most textbook cases of retinitis pigmentosa within this category. Clinically it matters because it predicts, with reasonable consistency, which visual abilities fade earliest and which last the longest.
For a patient from Nigeria who arrives with this exact term already noted on a referral, understanding that rod-first sequence clarifies a great deal from the first conversation onward, rather than leaving the label to guesswork.
10+
years Experience
years Experience
5000+
Patients treated
Patients treated
100+
Countries served
Countries served
NABH
Guided facility
Guided facility
Ocular Symptoms
With the rods affected first, difficulty seeing at night and a gradually narrowing field of vision tend to define the early and middle stages, while central vision and colour perception generally stay steady through that same window — only slipping later, once cone involvement begins. Many patients describe the change less as blurring and more as their surroundings closing in from the sides.
Underlying Causes
The rod-first pattern traces back to mutations in genes that matter disproportionately to rod cell survival, which explains much of the genetic crossover with the wider RP category. Inheritance may be dominant, recessive, or X-linked depending on the gene at fault, and the condition can occur in isolation or as part of a broader syndrome touching other organ systems.
Diagnosis for Nigerian Patients
Electroretinography does much of the heavy lifting in telling rod-cone dystrophy apart from its counterpart, cone-rod dystrophy: here, the rod-driven signal comes back markedly weaker than the cone-driven one, particularly in earlier stages. Visual field testing maps the extent of peripheral loss, while OCT shows how much of the photoreceptor layer remains intact.
Meet The Team
Our Eye Specialists
Dr. Pawan
Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience
Retinal disorders, diabetic retinopathy, and advanced retina procedures. Provides diagnostic evaluation and treatment planning for international patients.
Dr.Pallavee
Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Dr. Robin
Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Areas of Focus: Cataract surgery, corneal disorders, refractive procedures, and glaucoma management. Provides comprehensive eye care and surgical expertise for global patients.
Treatment Approach in India
Management follows the same regenerative and supportive framework applied across progressive dystrophies — stem cell therapy is evaluated for patients whose test results make them reasonable candidates, alongside practical support for adapting to reduced night and peripheral vision while central vision stays comparatively stable for longer.
Reviews
What Our Patients Say
DR NAAGALAKSHMI R
1 week ago
Asha Babbar
2 weeks ago
The overall experience at the RP Treatment Center was very good. The staff was supportive and caring, and we provided proper attention and guidance during treatment. The environment at the center was clean and comfortable. The doctors and staff tried to understand patients' needs and explained the treatment process well.
Overall, I am satisfied with the service and care. Highly recommended!
Overall, I am satisfied with the service and care. Highly recommended!
Harshita Kapoor
2 weeks ago
Life‑Changing Experience with RP Therapy”
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
After years of struggling with vision loss due to Retinitis Pigmentosa, I finally found hope here. The doctors were highly professional, explained the stem cell treatment in detail, and gave me confidence at every step. The therapy was smooth, and I’ve already noticed positive changes in my daily life. Their dedication, care, and advanced medical approach make this center truly trustworthy
Yash Chauhan
2 weeks ago
I had a really good experience at RP Treatment Centre. The doctor listened to my problem patiently and explained the treatment in a simple way. The staff was polite and the clinic was clean. I started feeling better after the treatment. Highly recommended!
pragya chauhan
2 weeks ago
Very satisfied with the service. The doctor is experienced and gives proper attention to every patient. The staff is friendly, and the overall environment is comfortable. Thank you, RP Treatment Centre, for the excellent care.
Manisha kapoor
2 weeks ago
I had been struggling with Retinitis Pigmentosa for years, and finding this center was truly life‑changing. The doctors provided a thorough medical evaluation and explained every step of the stem cell therapy process with clarity. The treatment was smooth, professional, and I noticed encouraging improvements in my vision within weeks. Their continuous follow‑up care and compassionate support made me feel confident throughout the journey. Highly recommended for anyone seeking advanced RP treatment in India.
Frequently Asked Questions
Is rod-cone dystrophy essentially just RP under a different name?
“There is considerable overlap. ‘Rod-cone dystrophy’ describes the sequence the disease follows — rods first, cones later — and that particular sequence applies to most cases that get clinically labelled retinitis pigmentosa.”
What actually separates rod-cone from cone-rod dystrophy?
”
It comes down to which cell type is affected first. Rod-cone dystrophy affects night and peripheral vision early while central and colour vision hold up longer; cone-rod dystrophy runs the opposite course, with central and colour vision affected sooner.”
Is my central vision likely to be affected eventually?
“In many rod-cone cases, eventually yes — central vision can decline once the disease has advanced enough to reach the cones, though the timeline for that shift varies considerably by gene and by individual.”
How frequently will follow-up monitoring be needed?
“That is decided case by case, guided by how quickly ERG and field results shift after the initial evaluation. Some patients only need annual review, while others with a faster-progressing pattern are seen more often.”
